1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cisplatin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Tablets 1.2.3 Injection 1.3 Market by Application 1.3.1 Global Cisplatin Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Testicular Cancer 1.3.3 Osteosarcoma 1.3.4 Breast Cancer 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cisplatin Market Perspective (2016-2027) 2.2 Cisplatin Growth Trends by Regions 2.2.1 Cisplatin Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cisplatin Historic Market Share by Regions (2016-2021) 2.2.3 Cisplatin Forecasted Market Size by Regions (2022-2027) 2.3 Cisplatin Industry Dynamic 2.3.1 Cisplatin Market Trends 2.3.2 Cisplatin Market Drivers 2.3.3 Cisplatin Market Challenges 2.3.4 Cisplatin Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cisplatin Players by Revenue 3.1.1 Global Top Cisplatin Players by Revenue (2016-2021) 3.1.2 Global Cisplatin Revenue Market Share by Players (2016-2021) 3.2 Global Cisplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cisplatin Revenue 3.4 Global Cisplatin Market Concentration Ratio 3.4.1 Global Cisplatin Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cisplatin Revenue in 2020 3.5 Cisplatin Key Players Head office and Area Served 3.6 Key Players Cisplatin Product Solution and Service 3.7 Date of Enter into Cisplatin Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cisplatin Breakdown Data by Type 4.1 Global Cisplatin Historic Market Size by Type (2016-2021) 4.2 Global Cisplatin Forecasted Market Size by Type (2022-2027) 5 Cisplatin Breakdown Data by Application 5.1 Global Cisplatin Historic Market Size by Application (2016-2021) 5.2 Global Cisplatin Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cisplatin Market Size (2016-2027) 6.2 North America Cisplatin Market Size by Type 6.2.1 North America Cisplatin Market Size by Type (2016-2021) 6.2.2 North America Cisplatin Market Size by Type (2022-2027) 6.2.3 North America Cisplatin Market Size by Type (2016-2027) 6.3 North America Cisplatin Market Size by Application 6.3.1 North America Cisplatin Market Size by Application (2016-2021) 6.3.2 North America Cisplatin Market Size by Application (2022-2027) 6.3.3 North America Cisplatin Market Size by Application (2016-2027) 6.4 North America Cisplatin Market Size by Country 6.4.1 North America Cisplatin Market Size by Country (2016-2021) 6.4.2 North America Cisplatin Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Cisplatin Market Size (2016-2027) 7.2 Europe Cisplatin Market Size by Type 7.2.1 Europe Cisplatin Market Size by Type (2016-2021) 7.2.2 Europe Cisplatin Market Size by Type (2022-2027) 7.2.3 Europe Cisplatin Market Size by Type (2016-2027) 7.3 Europe Cisplatin Market Size by Application 7.3.1 Europe Cisplatin Market Size by Application (2016-2021) 7.3.2 Europe Cisplatin Market Size by Application (2022-2027) 7.3.3 Europe Cisplatin Market Size by Application (2016-2027) 7.4 Europe Cisplatin Market Size by Country 7.4.1 Europe Cisplatin Market Size by Country (2016-2021) 7.4.2 Europe Cisplatin Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cisplatin Market Size (2016-2027) 8.2 Asia-Pacific Cisplatin Market Size by Type 8.2.1 Asia-Pacific Cisplatin Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cisplatin Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cisplatin Market Size by Type (2016-2027) 8.3 Asia-Pacific Cisplatin Market Size by Application 8.3.1 Asia-Pacific Cisplatin Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cisplatin Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cisplatin Market Size by Application (2016-2027) 8.4 Asia-Pacific Cisplatin Market Size by Region 8.4.1 Asia-Pacific Cisplatin Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cisplatin Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cisplatin Market Size (2016-2027) 9.2 Latin America Cisplatin Market Size by Type 9.2.1 Latin America Cisplatin Market Size by Type (2016-2021) 9.2.2 Latin America Cisplatin Market Size by Type (2022-2027) 9.2.3 Latin America Cisplatin Market Size by Type (2016-2027) 9.3 Latin America Cisplatin Market Size by Application 9.3.1 Latin America Cisplatin Market Size by Application (2016-2021) 9.3.2 Latin America Cisplatin Market Size by Application (2022-2027) 9.3.3 Latin America Cisplatin Market Size by Application (2016-2027) 9.4 Latin America Cisplatin Market Size by Country 9.4.1 Latin America Cisplatin Market Size by Country (2016-2021) 9.4.2 Latin America Cisplatin Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cisplatin Market Size (2016-2027) 10.2 Middle East & Africa Cisplatin Market Size by Type 10.2.1 Middle East & Africa Cisplatin Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cisplatin Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cisplatin Market Size by Type (2016-2027) 10.3 Middle East & Africa Cisplatin Market Size by Application 10.3.1 Middle East & Africa Cisplatin Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cisplatin Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cisplatin Market Size by Application (2016-2027) 10.4 Middle East & Africa Cisplatin Market Size by Country 10.4.1 Middle East & Africa Cisplatin Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cisplatin Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly and Company 11.1.1 Eli Lilly and Company Company Details 11.1.2 Eli Lilly and Company Business Overview 11.1.3 Eli Lilly and Company Cisplatin Introduction 11.1.4 Eli Lilly and Company Revenue in Cisplatin Business (2016-2021) 11.1.5 Eli Lilly and Company Recent Development 11.2 Hospira 11.2.1 Hospira Company Details 11.2.2 Hospira Business Overview 11.2.3 Hospira Cisplatin Introduction 11.2.4 Hospira Revenue in Cisplatin Business (2016-2021) 11.2.5 Hospira Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Cisplatin Introduction 11.3.4 Pfizer Revenue in Cisplatin Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 Bedford Pharmaceuticals 11.4.1 Bedford Pharmaceuticals Company Details 11.4.2 Bedford Pharmaceuticals Business Overview 11.4.3 Bedford Pharmaceuticals Cisplatin Introduction 11.4.4 Bedford Pharmaceuticals Revenue in Cisplatin Business (2016-2021) 11.4.5 Bedford Pharmaceuticals Recent Development 11.5 Alvogen 11.5.1 Alvogen Company Details 11.5.2 Alvogen Business Overview 11.5.3 Alvogen Cisplatin Introduction 11.5.4 Alvogen Revenue in Cisplatin Business (2016-2021) 11.5.5 Alvogen Recent Development 11.6 Athenex Pharmaceutical 11.6.1 Athenex Pharmaceutical Company Details 11.6.2 Athenex Pharmaceutical Business Overview 11.6.3 Athenex Pharmaceutical Cisplatin Introduction 11.6.4 Athenex Pharmaceutical Revenue in Cisplatin Business (2016-2021) 11.6.5 Athenex Pharmaceutical Recent Development 11.7 Gland Pharma (Fosun Pharma) 11.7.1 Gland Pharma (Fosun Pharma) Company Details 11.7.2 Gland Pharma (Fosun Pharma) Business Overview 11.7.3 Gland Pharma (Fosun Pharma) Cisplatin Introduction 11.7.4 Gland Pharma (Fosun Pharma) Revenue in Cisplatin Business (2016-2021) 11.7.5 Gland Pharma (Fosun Pharma) Recent Development 11.8 West-Ward Pharmaceuticals 11.8.1 West-Ward Pharmaceuticals Company Details 11.8.2 West-Ward Pharmaceuticals Business Overview 11.8.3 West-Ward Pharmaceuticals Cisplatin Introduction 11.8.4 West-Ward Pharmaceuticals Revenue in Cisplatin Business (2016-2021) 11.8.5 West-Ward Pharmaceuticals Recent Development 11.9 WG Critical Care 11.9.1 WG Critical Care Company Details 11.9.2 WG Critical Care Business Overview 11.9.3 WG Critical Care Cisplatin Introduction 11.9.4 WG Critical Care Revenue in Cisplatin Business (2016-2021) 11.9.5 WG Critical Care Recent Development 11.10 David Bull Laboratories 11.10.1 David Bull Laboratories Company Details 11.10.2 David Bull Laboratories Business Overview 11.10.3 David Bull Laboratories Cisplatin Introduction 11.10.4 David Bull Laboratories Revenue in Cisplatin Business (2016-2021) 11.10.5 David Bull Laboratories Recent Development 11.11 Omega Laboratories 11.11.1 Omega Laboratories Company Details 11.11.2 Omega Laboratories Business Overview 11.11.3 Omega Laboratories Cisplatin Introduction 11.11.4 Omega Laboratories Revenue in Cisplatin Business (2016-2021) 11.11.5 Omega Laboratories Recent Development 11.12 Fresenius Kabi 11.12.1 Fresenius Kabi Company Details 11.12.2 Fresenius Kabi Business Overview 11.12.3 Fresenius Kabi Cisplatin Introduction 11.12.4 Fresenius Kabi Revenue in Cisplatin Business (2016-2021) 11.12.5 Fresenius Kabi Recent Development 11.13 TEVA 11.13.1 TEVA Company Details 11.13.2 TEVA Business Overview 11.13.3 TEVA Cisplatin Introduction 11.13.4 TEVA Revenue in Cisplatin Business (2016-2021) 11.13.5 TEVA Recent Development 11.14 Mylan Pharmaceuticals 11.14.1 Mylan Pharmaceuticals Company Details 11.14.2 Mylan Pharmaceuticals Business Overview 11.14.3 Mylan Pharmaceuticals Cisplatin Introduction 11.14.4 Mylan Pharmaceuticals Revenue in Cisplatin Business (2016-2021) 11.14.5 Mylan Pharmaceuticals Recent Development 11.15 Yunnan Plant Pharmaceutical 11.15.1 Yunnan Plant Pharmaceutical Company Details 11.15.2 Yunnan Plant Pharmaceutical Business Overview 11.15.3 Yunnan Plant Pharmaceutical Cisplatin Introduction 11.15.4 Yunnan Plant Pharmaceutical Revenue in Cisplatin Business (2016-2021) 11.15.5 Yunnan Plant Pharmaceutical Recent Development 11.16 Yunnan Biological Valley Pharmaceutical 11.16.1 Yunnan Biological Valley Pharmaceutical Company Details 11.16.2 Yunnan Biological Valley Pharmaceutical Business Overview 11.16.3 Yunnan Biological Valley Pharmaceutical Cisplatin Introduction 11.16.4 Yunnan Biological Valley Pharmaceutical Revenue in Cisplatin Business (2016-2021) 11.16.5 Yunnan Biological Valley Pharmaceutical Recent Development 11.17 Dezhou de Pharmaceutical 11.17.1 Dezhou de Pharmaceutical Company Details 11.17.2 Dezhou de Pharmaceutical Business Overview 11.17.3 Dezhou de Pharmaceutical Cisplatin Introduction 11.17.4 Dezhou de Pharmaceutical Revenue in Cisplatin Business (2016-2021) 11.17.5 Dezhou de Pharmaceutical Recent Development 11.18 Jiangsu Haosen Pharmaceutical Group 11.18.1 Jiangsu Haosen Pharmaceutical Group Company Details 11.18.2 Jiangsu Haosen Pharmaceutical Group Business Overview 11.18.3 Jiangsu Haosen Pharmaceutical Group Cisplatin Introduction 11.18.4 Jiangsu Haosen Pharmaceutical Group Revenue in Cisplatin Business (2016-2021) 11.18.5 Jiangsu Haosen Pharmaceutical Group Recent Development 11.18 Qilu Pharmaceutical .1 Qilu Pharmaceutical Company Details .2 Qilu Pharmaceutical Business Overview .3 Qilu Pharmaceutical Cisplatin Introduction .4 Qilu Pharmaceutical Revenue in Cisplatin Business (2016-2021) .5 Qilu Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cisplatin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Tablets Table 3. Key Players of Injection Table 4. Global Cisplatin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Cisplatin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Cisplatin Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Cisplatin Market Share by Regions (2016-2021) Table 8. Global Cisplatin Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Cisplatin Market Share by Regions (2022-2027) Table 10. Cisplatin Market Trends Table 11. Cisplatin Market Drivers Table 12. Cisplatin Market Challenges Table 13. Cisplatin Market Restraints Table 14. Global Cisplatin Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Cisplatin Market Share by Players (2016-2021) Table 16. Global Top Cisplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cisplatin as of 2020) Table 17. Ranking of Global Top Cisplatin Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Cisplatin Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Cisplatin Product Solution and Service Table 21. Date of Enter into Cisplatin Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Cisplatin Market Size by Type (2016-2021) (US$ Million) Table 24. Global Cisplatin Revenue Market Share by Type (2016-2021) Table 25. Global Cisplatin Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Cisplatin Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Cisplatin Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Cisplatin Revenue Market Share by Application (2016-2021) Table 29. Global Cisplatin Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Cisplatin Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Cisplatin Market Size by Type (2016-2021) (US$ Million) Table 32. North America Cisplatin Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Cisplatin Market Size by Application (2016-2021) (US$ Million) Table 34. North America Cisplatin Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Cisplatin Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Cisplatin Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Cisplatin Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Cisplatin Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Cisplatin Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Cisplatin Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Cisplatin Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Cisplatin Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Cisplatin Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Cisplatin Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Cisplatin Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Cisplatin Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Cisplatin Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Cisplatin Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Cisplatin Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Cisplatin Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Cisplatin Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Cisplatin Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Cisplatin Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Cisplatin Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Cisplatin Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Cisplatin Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Cisplatin Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Cisplatin Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Cisplatin Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Cisplatin Market Size by Country (2022-2027) & (US$ Million) Table 61. Eli Lilly and Company Company Details Table 62. Eli Lilly and Company Business Overview Table 63. Eli Lilly and Company Cisplatin Product Table 64. Eli Lilly and Company Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 65. Eli Lilly and Company Recent Development Table 66. Hospira Company Details Table 67. Hospira Business Overview Table 68. Hospira Cisplatin Product Table 69. Hospira Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 70. Hospira Recent Development Table 71. Pfizer Company Details Table 72. Pfizer Business Overview Table 73. Pfizer Cisplatin Product Table 74. Pfizer Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 75. Pfizer Recent Development Table 76. Bedford Pharmaceuticals Company Details Table 77. Bedford Pharmaceuticals Business Overview Table 78. Bedford Pharmaceuticals Cisplatin Product Table 79. Bedford Pharmaceuticals Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 80. Bedford Pharmaceuticals Recent Development Table 81. Alvogen Company Details Table 82. Alvogen Business Overview Table 83. Alvogen Cisplatin Product Table 84. Alvogen Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 85. Alvogen Recent Development Table 86. Athenex Pharmaceutical Company Details Table 87. Athenex Pharmaceutical Business Overview Table 88. Athenex Pharmaceutical Cisplatin Product Table 89. Athenex Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 90. Athenex Pharmaceutical Recent Development Table 91. Gland Pharma (Fosun Pharma) Company Details Table 92. Gland Pharma (Fosun Pharma) Business Overview Table 93. Gland Pharma (Fosun Pharma) Cisplatin Product Table 94. Gland Pharma (Fosun Pharma) Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 95. Gland Pharma (Fosun Pharma) Recent Development Table 96. West-Ward Pharmaceuticals Company Details Table 97. West-Ward Pharmaceuticals Business Overview Table 98. West-Ward Pharmaceuticals Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 99. West-Ward Pharmaceuticals Recent Development Table 100. WG Critical Care Company Details Table 101. WG Critical Care Business Overview Table 102. WG Critical Care Cisplatin Product Table 103. WG Critical Care Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 104. WG Critical Care Recent Development Table 105. David Bull Laboratories Company Details Table 106. David Bull Laboratories Business Overview Table 107. David Bull Laboratories Cisplatin Product Table 108. David Bull Laboratories Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 109. David Bull Laboratories Recent Development Table 110. Omega Laboratories Company Details Table 111. Omega Laboratories Business Overview Table 112. Omega Laboratories Cisplatin Product Table 113. Omega Laboratories Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 114. Omega Laboratories Recent Development Table 115. Fresenius Kabi Company Details Table 116. Fresenius Kabi Business Overview Table 117. Fresenius Kabi Cisplatin Product Table 118. Fresenius Kabi Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 119. Fresenius Kabi Recent Development Table 120. TEVA Company Details Table 121. TEVA Business Overview Table 122. TEVA Cisplatin Product Table 123. TEVA Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 124. TEVA Recent Development Table 125. Mylan Pharmaceuticals Company Details Table 126. Mylan Pharmaceuticals Business Overview Table 127. Mylan Pharmaceuticals Cisplatin Product Table 128. Mylan Pharmaceuticals Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 129. Mylan Pharmaceuticals Recent Development Table 130. Yunnan Plant Pharmaceutical Company Details Table 131. Yunnan Plant Pharmaceutical Business Overview Table 132. Yunnan Plant Pharmaceutical Cisplatin Product Table 133. Yunnan Plant Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 134. Yunnan Plant Pharmaceutical Recent Development Table 135. Yunnan Biological Valley Pharmaceutical Company Details Table 136. Yunnan Biological Valley Pharmaceutical Business Overview Table 137. Yunnan Biological Valley Pharmaceutical Cisplatin Product Table 138. Yunnan Biological Valley Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 139. Yunnan Biological Valley Pharmaceutical Recent Development Table 140. Dezhou de Pharmaceutical Company Details Table 141. Dezhou de Pharmaceutical Business Overview Table 142. Dezhou de Pharmaceutical Cisplatin Product Table 143. Dezhou de Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 144. Dezhou de Pharmaceutical Recent Development Table 145. Jiangsu Haosen Pharmaceutical Group Company Details Table 146. Jiangsu Haosen Pharmaceutical Group Business Overview Table 147. Jiangsu Haosen Pharmaceutical Group Cisplatin Product Table 148. Jiangsu Haosen Pharmaceutical Group Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 149. Jiangsu Haosen Pharmaceutical Group Recent Development Table 150. Qilu Pharmaceutical Company Details Table 151. Qilu Pharmaceutical Business Overview Table 152. Qilu Pharmaceutical Cisplatin Product Table 153. Qilu Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million) Table 154. Qilu Pharmaceutical Recent Development Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Global Cisplatin Market Share by Type: 2020 VS 2027 Figure 2. Tablets Features Figure 3. Injection Features Figure 4. Global Cisplatin Market Share by Application: 2020 VS 2027 Figure 5. Testicular Cancer Case Studies Figure 6. Osteosarcoma Case Studies Figure 7. Breast Cancer Case Studies Figure 8. Cisplatin Report Years Considered Figure 9. Global Cisplatin Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Cisplatin Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Cisplatin Market Share by Regions: 2020 VS 2027 Figure 12. Global Cisplatin Market Share by Regions (2022-2027) Figure 13. Global Cisplatin Market Share by Players in 2020 Figure 14. Global Top Cisplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cisplatin as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Cisplatin Revenue in 2020 Figure 16. Global Cisplatin Revenue Market Share by Type (2016-2021) Figure 17. Global Cisplatin Revenue Market Share by Type (2022-2027) Figure 18. North America Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Cisplatin Market Share by Type (2016-2027) Figure 20. North America Cisplatin Market Share by Application (2016-2027) Figure 21. North America Cisplatin Market Share by Country (2016-2027) Figure 22. United States Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Cisplatin Market Share by Type (2016-2027) Figure 26. Europe Cisplatin Market Share by Application (2016-2027) Figure 27. Europe Cisplatin Market Share by Country (2016-2027) Figure 28. Germany Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Cisplatin Market Share by Type (2016-2027) Figure 36. Asia-Pacific Cisplatin Market Share by Application (2016-2027) Figure 37. Asia-Pacific Cisplatin Market Share by Region (2016-2027) Figure 38. China Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Cisplatin Market Share by Type (2016-2027) Figure 46. Latin America Cisplatin Market Share by Application (2016-2027) Figure 47. Latin America Cisplatin Market Share by Country (2016-2027) Figure 48. Mexico Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Cisplatin Market Share by Type (2016-2027) Figure 52. Middle East & Africa Cisplatin Market Share by Application (2016-2027) Figure 53. Middle East & Africa Cisplatin Market Share by Country (2016-2027) Figure 54. Turkey Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Eli Lilly and Company Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 58. Hospira Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 59. Pfizer Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 60. Bedford Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 61. Alvogen Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 62. Athenex Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 63. Gland Pharma (Fosun Pharma) Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 64. West-Ward Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 65. WG Critical Care Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 66. David Bull Laboratories Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 67. Omega Laboratories Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 68. Fresenius Kabi Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 69. TEVA Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 70. Mylan Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 71. Yunnan Plant Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 72. Yunnan Biological Valley Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 73. Dezhou de Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 74. Jiangsu Haosen Pharmaceutical Group Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 75. Qilu Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Eli Lilly and Company Hospira Pfizer Bedford Pharmaceuticals Alvogen Athenex Pharmaceutical Gland Pharma (Fosun Pharma) West-Ward Pharmaceuticals WG Critical Care David Bull Laboratories Omega Laboratories Fresenius Kabi TEVA Mylan Pharmaceuticals Yunnan Plant Pharmaceutical Yunnan Biological Valley Pharmaceutical Dezhou de Pharmaceutical Jiangsu Haosen Pharmaceutical Group Qilu Pharmaceutical